Gatsina 400 mg (Tablet)
Unit Price: ৳ 11.00 (2 x 10: ৳ 220.00)
Strip Price: ৳ 110.00
Medicine Details
Category | Details |
---|---|
Generic | Gatifloxacin |
Company | Ibn Sina Pharmaceuticals Ltd. |
Indications
- Acute bacterial exacerbation of chronic bronchitis
- Acute sinusitis
- Community-acquired pneumonia
- Uncomplicated skin and skin structure infections
- Uncomplicated urinary tract infections
- Complicated urinary tract infections
- Pyelonephritis
- Uncomplicated urethral and cervical gonorrhea
- Acute, uncomplicated rectal infections in women
Pharmacology
Acts by inhibiting DNA synthesis in susceptible organisms via inhibition of both DNA gyrase and topoisomerase IV.
Dosage
- Acute Bacterial Exacerbation of Chronic Bronchitis: 400 mg 5 days
- Acute Sinusitis: 400 mg 10 days
- Community-acquired Pneumonia: 400 mg 7-14 days
- Uncomplicated Skin and Skin Structure Infections: 400 mg 7-10 days
- Uncomplicated Urinary Tract Infections: 400 mg Single Dose or 200 mg 3 days
- Complicated Urinary Tract Infections: 400 mg 7-10 days
- Acute Pyelonephritis: 400 mg 7-10 days
- Uncomplicated Urethral Gonnorrhea in Men: 400 mg Single dose
Administration
Can be administered without regard to food.
Contraindications
Contraindicated in patients with a history of hypersensitivity of Gatifloxacin, quinolone antimicrobial agents, or any other components of this product.
Side Effects
- Nausea
- Vomiting
- Stomach pain
- Diarrhea
- Dizziness
- Headache
Pregnancy & Lactation
- Use during pregnancy only if the potential benefit outweighs the potential risk to the fetus
- Caution should be exercised when administered to a nursing woman
Precautions & Warnings
Should be administered with caution in the presence of renal insufficiency.
Use in Special Populations
- Renal Impaired patient:
- Creatinine Clearance 40 mL/min: 400 mg every day
- Creatinine Clearance < 40 mL/min: 400 mg 200 mg every day
- Dialysis patients:
- Hemodialysis: 400 mg 200 mg every day
- Continuous peritoneal dialysis: 400 mg 200 mg every day
- Pediatric use: The safety and effectiveness not established in pediatric populations.
Overdose Effects
Exhibits low potential for acute toxicity. In the event of acute oral overdose, the stomach should be emptied by inducing vomiting or by gastric lavage. The patient should be carefully observed and given symptomatic and supportive treatment.
Therapeutic Class
4-Quinolone preparations